NR- not reported NR*- not reached Clinical outcome data with use of bispecific antibodies.

The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. YIA Special Competitions are open in ...

This page contains important information for corporate and institutional public relations professionals about ASCO Meetings. Once an abstract is submitted to an ASCO Meeting, the abstract and study ...

The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund ...

The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...

Our grants and awards support basic, translational and clinical cancer research done by gifted physician-scientists at every stage of their careers, from the best and brightest among young ...

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

The Association for Clinical Oncology (ASCO) offers multiple ways for you and your colleagues to engage with policymakers and educate them on ASCO’s advocacy priorities, while leveraging your insights ...

ASCO’s growing roster of highly respected, award-winning reports play an important role in informing the public, media, and government officials about the state of cancer care in America, advances in ...

83.3% (n=25) vs 6.7% (n=2) vs 10% (n=3) 21.8% (n=8) vs 15.6% (n=2) vs 59.3% (n=19) 44.4% (n=4) vs 11.1% (n=1) vs 44.4% (n=4) <0.001 ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...